Cargando…

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4

OBJECTIVES: We studied the frequency and risk factors for loss of long-term non-progressor (LTNP) and HIV controller (HIC) status among patients identified as such in 2005 in the French Hospital Database on HIV (FHDH-ANRS CO4). METHODS: We selected patients who were treatment-naïve and asymptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grabar, Sophie, Selinger-Leneman, Hana, Abgrall, Sophie, Pialoux, Gilles, Weiss, Laurence, Costagliola, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624574/ https://www.ncbi.nlm.nih.gov/pubmed/28968404 http://dx.doi.org/10.1371/journal.pone.0184441

Ejemplares similares

Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017
por: Castry, Mathieu, et al.
Publicado: (2021)

Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination
por: Lusivika-Nzinga, Clovis, et al.
Publicado: (2017)

CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory
por: Boufassa, Faroudy, et al.
Publicado: (2011)

Syphilis infection is associated with an increase in plasma viral load in HIV infected patients: results from the FHDH cohort — ANRS CO4
por: Jarzebowski, W, et al.
Publicado: (2010)

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study
por: Shili-Masmoudi, Sarah, et al.
Publicado: (2019)

Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France
por: Marty, Lise, et al.
Publicado: (2022)

Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
por: Baldé, Aliou, et al.
Publicado: (2020)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Epidemiology of Kaposi’s Sarcoma
por: Grabar, Sophie, et al.
Publicado: (2021)

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial
por: Launay, Odile, et al.
Publicado: (2007)

Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment
por: Protiere, Christel, et al.
Publicado: (2020)

Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV‐1 infection: results from a longitudinal study in the French ANRS Primo cohort
por: Novelli, Sophie, et al.
Publicado: (2020)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France
por: de Monteynard, Laure-Amélie, et al.
Publicado: (2015)

Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
por: Plaçais, Léo, et al.
Publicado: (2021)

Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013)

NKG2C(+) memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France
por: de Monteynard, Laure-Amélie, et al.
Publicado: (2018)

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010
por: Loko, Marc-Arthur, et al.
Publicado: (2010)

Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2012)

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)
por: Yaya, Issifou, et al.
Publicado: (2018)

Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
por: Michel, Laurent, et al.
Publicado: (2011)

Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial
por: Baisley, Kathy, et al.
Publicado: (2022)

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study
por: Breton, Guillaume, et al.
Publicado: (2022)

Critical Importance of Long-Term Adherence to Care in HIV Infected Patients in the cART Era: New Insights from Pneumocystis jirovecii Pneumonia Cases over 2004–2011 in the FHDH-ANRS CO4 Cohort
por: Denis, Blandine, et al.
Publicado: (2014)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients
por: Stefani, Chiara, et al.
Publicado: (2022)

Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors
por: Lungu, Cynthia, et al.
Publicado: (2023)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients
por: Yaya, Issifou, et al.
Publicado: (2018)

New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study
por: Frange, Pierre, et al.
Publicado: (2008)

Machine Learning to Improve the Effectiveness of ANRS in Predicting HIV Drug Resistance
por: Singh, Yashik
Publicado: (2017)

Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort
por: Fink, Elizabeth, et al.
Publicado: (2016)

Bridging HIV-1 Cellular Latency and Clinical Long-Term Non-Progressor: An Interactomic View
por: Yang, Jin, et al.
Publicado: (2013)

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera
por: Hao, Yuxia, et al.
Publicado: (2015)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_djneb4hbsgmk6te6it19rd3eij